Molecular Tumor Board
- Offered byCoursera
Molecular Tumor Board at Coursera Overview
Duration | 42 hours |
Start from | Start Now |
Total fee | Free |
Mode of learning | Online |
Official Website | Explore Free Course  |
Credential | Certificate |
Molecular Tumor Board at Coursera Highlights
- Earn a certificate from Coursera
- Learn from industry experts
Molecular Tumor Board at Coursera Course details
- Se trata de un curso que nace a raÃz de una de las sesiones formativas que realiza cada 15 dÃas el Servicio de OncologÃa Médica del Hospital ClÃnic de Barcelona (HCB)
- En este curso se presentan casos clÃnicos simulando un MTB de tumores sólidos, con un objetivo principal, mejorar el conocimiento especÃfico del impacto clÃnico del perfil molecular en tumores sólidos
- Está destinado a médicos oncólogos y a estudiantes y profesionales vinculados a la oncologÃa médica. Cada seminario que conforma el curso lo presenta un profesional de una patologÃa diferente del Servicio de OncologÃa Médica del HCB.
Molecular Tumor Board at Coursera Curriculum
Is there any role for presicion medicine in ampullary cancer? by Dra. Tamara Sauri
Is there any role for presicion medicine in ampullary cancer?
12 Publicaciones recomendadas
Is there any role for presicion medicine in ampullary cancer?
Targeted therapy in upper tract urinary cancer by Dra. Laia Fernández
Targeted therapy in upper tract urinary cancer
8 Publicaciones recomendadas
Targeted therapy in upper tract urinary cancer
What are the odds? Not everything that glitters is gold by Dr. Lucio Ghiglione
What are the odds? Not everything that glitters is gold
10 Publicaciones recomendadas
What are the odds? Not everything that glitters is gold
Beyond HER2 amplification: do HER2 mutations play a role in Breast Cancer? by Dra. Isabel García
Beyond HER2 amplification: do HER2 mutations play a role in Breast Cancer?
11 Publicaciones recomendadas
Beyond HER2 amplification: do HER2 mutations play a role in Breast Cancer?
Unexpected response to IO in a patient with advanced colorectal cancer by Dr. Juan Carlos Laguna
Unexpected response to IO in a patient with advanced colorectal cancer
5 Publicaciones recomendadas
Unexpected response to IO in a patient with advanced colorectal cancer
Ataxia Teleangectasia Mutations (ATM) and advanced prostate cancer by Dra. Caterina Aversa
Ataxia Teleangectasia Mutations (ATM) and advanced prostate cancer
10 Publicaciones recomendadas
Ataxia Teleangectasia Mutations (ATM) and advanced prostate cancer
dMMR/MSI-H facor predictivo en CCR localizado by Dr. Reinaldo Moreno
dMMR/MSI-H facor predictivo en CCR localizado
6 Publicaciones recomendadas
dMMR/MSI-H facor predictivo en CCR localizado
Multiples tumors in a young patient ¿genetic or casuality? by Dra. Laura González
Multiples tumors in a young patient ¿genetic or casuality?
8 Publicaciones recomendadas
Multiples tumors in a young patient ¿genetic or casuality?
Tackling KRAS G12C mutation in NSCLC by Dr. Francisco Javier Muñoz
Tackling KRAS G12C mutation in NSCLC
13 Publicaciones recomendadas
Tackling KRAS G12C mutation in NSCLC
Presicion Medicine in NSCLC by Dra. Laura Mezquita
Presicion Medicine in NSCLC
4 Publicaciones recomendadas
Presicion Medicine in NSCLC
Molecular characterization of agressive prostate cancer by Dra. Marta Garcia de Herreros
Molecular characterization of agressive prostate cancer
7 Publicaciones recomendadas
Molecular characterization of agressive prostate cancer
Understanding the True Impact of Molecular Alterations by Dr. David Pesántez
Understanding the True Impact of Molecular Alterations
5 Publicaciones recomendadas
Understanding the True Impact of Molecular Alterations
PARP inhibitors in somatic BRCA-mutant breast cancer: beyond germline pathogenetic variants by Dr. Francesco Schettini
PARP inhibitors in somatic BRCA-mutant breast cancer: beyond germline pathogenetic variants
8 Publicaciones recomendadas
PARP inhibitors in somatic BRCA-mutant breast cancer: beyond germline pathogenetic variants
Personalized Treatment Strategies in Metastatic Colon Cancer by Dra. Mariam Rojas
Personalized Treatment Strategies in Metastatic Colon Cancer
8 Publicaciones recomendadas
Personalized Treatment Strategies in Metastatic Colon Cancer
Beyond BRCAs in prostate cancer by Dr. Òscar Reig
Beyond BRCAs in prostate cancer
5 Publicaciones recomendadas
Beyond BRCAs in prostate cancer
Targeted cholangiocarcinoma: myth or reality by Dr. Iván Victoria
Targeted cholangiocarcinoma: myth or reality
5 Publicaciones recomendadas
Targeted cholangiocarcinoma: myth or reality
Rediscovering the uncharted EGFR uncommon mutations by Dra. Teresa Gorria
Rediscovering the uncharted EGFR uncommon mutations
8 Publicaciones recomendadas
Rediscovering the uncharted EGFR uncommon mutations
Molecular Tumor Board at Coursera Admission Process
Important Dates
Other courses offered by Coursera
Student Forum
Anything you would want to ask experts?